Compositions and Methods for Enhancing Cancer Immunotherapy
Technology
E-272-2012
Patent ID
E-272-2012-0-US-03
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
US20150275209A1
Application Number
14/436,947
IC
NCI
Date Filed
Date Issued
Patent PDF